Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	0.5 mg BID TC-5214	160
Overall Study	STARTED	2 mg BID TC-5214	160
Overall Study	STARTED	4 mg BID TC-5214	160
Overall Study	STARTED	Placebo	161
Overall Study	Received Treatment	0.5 mg BID TC-5214	160
Overall Study	Received Treatment	2 mg BID TC-5214	158
Overall Study	Received Treatment	4 mg BID TC-5214	158
Overall Study	Received Treatment	Placebo	160
Overall Study	COMPLETED	0.5 mg BID TC-5214	127
Overall Study	COMPLETED	2 mg BID TC-5214	116
Overall Study	COMPLETED	4 mg BID TC-5214	110
Overall Study	COMPLETED	Placebo	129
Overall Study	NOT COMPLETED	0.5 mg BID TC-5214	33
Overall Study	NOT COMPLETED	2 mg BID TC-5214	44
Overall Study	NOT COMPLETED	4 mg BID TC-5214	50
Overall Study	NOT COMPLETED	Placebo	32

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01153347/flow